Denizot Y, Chaussade S, Colombel J F, Benveniste J, Couturier D
I.N.S.E.R.M. U200, Clamart.
C R Acad Sci III. 1991;312(7):329-33.
Paf-acether (platelet-activating factor, paf) is one of the most potent inflammatory mediators synthesised by and acting on most inflammatory cells. Paf causes gastric ulcerations and ischemic bowel necrosis. Recently, we described the presence of paf in stools of patients bearing ileal pouch-anal anastomosis with pouchitis. These findings prompted us to search for the presence of paf in stools of patients suffering from inflammatory bowel diseases: Crohn's disease and ulcerative colitis. The fraction corresponding to paf isolated from stools exhibited the same physicochemical and biological characteristics as synthetic paf. Reverse-phase high performance liquid chromatography revealed 80% of C16 and 20% of C18 paf. The presence of a biologically active phospholipid in human stools may bring new perspectives with respect to the study of gastrointestinal diseases as well as the use of paf antagonists in the treatment of inflammatory bowel diseases.
血小板活化因子(PAF)是由大多数炎症细胞合成并作用于这些细胞的最有效的炎症介质之一。PAF可导致胃溃疡和缺血性肠坏死。最近,我们描述了患有袋炎的回肠袋肛管吻合术患者粪便中存在PAF。这些发现促使我们去探寻炎症性肠病(克罗恩病和溃疡性结肠炎)患者粪便中是否存在PAF。从粪便中分离出的与PAF相对应的部分表现出与合成PAF相同的物理化学和生物学特性。反相高效液相色谱显示C16的PAF占80%,C18的PAF占20%。人类粪便中存在生物活性磷脂可能会为胃肠道疾病的研究以及PAF拮抗剂在炎症性肠病治疗中的应用带来新的前景。